Skip to main content

Ethicon Manages To Toss Defective Pelvic Mesh Claims

Ethicon Manages To Toss Defective Pelvic Mesh Claims

Ethicon Manages To Toss Defective Pelvic Mesh Claims

Introduction

On April 17,  a Philadelphia jury ruled in favor of a Johnson & Johnson unit, tossing claims made by a woman that the company's defectively designed pelvic mesh implant caused her severe pain and vaginal complications.

Though the jury agreed that J&J's subsidiary Ethicon Inc. was negligent in designing and marketing its TVT-Secur mesh implant, the jury determined that negligence was not the reason for the injuries the Philadelphia-area resident suffered from the device. The plaintiff was implanted with the TVT-Secur mesh in 2008 to treat her stress urinary incontinence. However, she experienced painful side-effects, and her condition seemed to worsen over the years. In her lawsuit, she asserted that Ethicon rushed the product to the market in 2006, without adequate clinical testing. The mesh implant was pulled from the market in 2012. Defendants argued that the woman's injuries were not linked to the mesh implant and that the product cannot be regarded as defective merely because it failed to cure her incontinence. The jury returned a defense verdict after about six hours of deliberation, ending the three-and-half-week trial.

Ethicon pelvic mesh lawsuits are consolidated as a part of a multidistrict litigation (MDL No. 2327; In Re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation) before U.S. District Judge Joseph R. Goodwin in the Southern District of West Virginia.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!